Indo Borax & Chemicals
- P/E
- 24.77
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 15.40%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹17.55
- Book Value
- ₹120.47
- Market Cap
- —
- P/E (TTM)
- 24.77
- P/B
- 3.61
- ROE
- 10.10%
- Dividend Yield
- 9.23%
- EBITDA
- ₹59.60 Cr
- 52W High
- ₹542.80
- 52W Low
- ₹230.45
- Day Range
- ₹412.35 – ₹443.70
- Volume
- 62,213
Peer Comparison
Commodities › Chemicals › Commodity Chemicals
| ₹2,458.70 | 33.71 | ₹72,345 Cr | 4.76 | 0.21% | 14.30% | 14.60% | ₹17,001 Cr | ₹2,162 Cr | |
| ₹603.10 | — | ₹15,550 Cr | 0.72 | 1.80% | 1.27% | 3.42% | ₹15,120 Cr | −₹1,971 Cr | |
| ₹1,146.40 | 14.70 | ₹14,323 Cr | 2.11 | 0.89% | 10.90% | 11.40% | ₹12,104 Cr | ₹984 Cr | |
| ₹3,496.70 | 104.85 | ₹7,452 Cr | 10.47 | 0.13% | 20.30% | 23.90% | ₹722 Cr | ₹68 Cr | |
| ₹470.70 | 6.67 | ₹6,914 Cr | 0.74 | 4.52% | 9.14% | 12.00% | ₹8,410 Cr | ₹1,037 Cr | |
| ₹567.75 | 62.80 | ₹4,086 Cr | 0.80 | 3.19% | −0.05% | 1.42% | ₹4,498 Cr | ₹66 Cr | |
| ₹407.30 | 8.11 | ₹3,725 Cr | 1.05 | 2.98% | 13.00% | 17.40% | ₹3,138 Cr | ₹473 Cr | |
| ₹434.75 | 24.77 | ₹1,382 Cr | 3.61 | 9.23% | 10.10% | 15.40% | ₹232 Cr | ₹56 Cr | |
| Median 8 companies | ₹585.43 | 24.77 | ₹7,183 Cr | 1.58 | 2.39% | 10.50% | 13.30% | ₹6,454 Cr | ₹271 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 85
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 51
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 88
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 91
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 88
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Debtor days have improved from 25.5 to 17.6 days.
- Promoter holding has increased by 7.61% over last quarter.
Weaknesses
6- The company has delivered a poor sales growth of 8.37% over past five years.
- Company has a low return on equity of 12.2% over last 3 years.
- Promoters have pledged 100% of their holding.
- Earnings include an other income of Rs.25.1 Cr.
- Dividend payout has been low at 7.39% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -13.7%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 6 | 5 |
| Oscillators | Bearish | 3 | 6 | 0 |
| Moving Averages | Neutral | 5 | 0 | 5 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Neutral
Key readings
- RSI (14)
- 47.78
- Neutral
- MACD (12,26,9)
- −15.27
- Bearish
- SMA (50)
- 468.54
- Bearish
- SMA (200)
- 353.44
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +11.88% |
|---|---|
| 5Y | +8.35% |
| 3Y | −1.50% |
| 1Y | +22.86% |
| TTM | +28.89% |
Net profit
| 10Y | +18.71% |
|---|---|
| 5Y | +8.02% |
| 3Y | −0.66% |
| 1Y | +16.28% |
| TTM | +47.37% |
Operating cash flow
| 10Y | +17.06% |
|---|---|
| 5Y | +40.31% |
| 3Y | +13.19% |
| 1Y | Turned positive |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +3.33 pp |
|---|---|
| 5Y | −10.09 pp |
| 3Y | −7.09 pp |
| 1Y | −5.82 pp |
| TTM | −0.37 pp |
Revenue by year
| Mar 2017 | ₹67.00 Cr |
|---|---|
| Mar 2018 | ₹101 Cr |
| Mar 2019 | ₹128 Cr |
| Mar 2020 | ₹115 Cr |
| Mar 2021 | ₹144 Cr |
| Mar 2022 | ₹176 Cr |
| Mar 2023 | ₹225 Cr |
| Mar 2024 | ₹191 Cr |
| Mar 2025 | ₹175 Cr |
| Mar 2026 | ₹215 Cr |
Net profit by year
| Mar 2017 | ₹8.00 Cr |
|---|---|
| Mar 2018 | ₹13.00 Cr |
| Mar 2019 | ₹18.00 Cr |
| Mar 2020 | ₹17.00 Cr |
| Mar 2021 | ₹34.00 Cr |
| Mar 2022 | ₹36.00 Cr |
| Mar 2023 | ₹51.00 Cr |
| Mar 2024 | ₹39.00 Cr |
| Mar 2025 | ₹43.00 Cr |
| Mar 2026 | ₹50.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 55 | 47 | 44 | 45 | 50 | 38 | 38 | 50 | 54 | 58 | 41 | 63 | 70 |
| Expenses | 43 | 37 | 35 | 34 | 33 | 29 | 27 | 40 | 41 | 47 | 32 | 50 | 51 |
| Operating Profit | 12 | 10 | 9 | 12 | 16 | 9 | 10 | 10 | 12 | 10 | 9 | 13 | 20 |
| OPM % | 22% | 22% | 21% | 25% | 33% | 24% | 27% | 20% | 23% | 18% | 21% | 20% | 28% |
| Other Income | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 13 | 4 | 5 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| PBT | 14 | 12 | 11 | 14 | 19 | 13 | 14 | 13 | 14 | 23 | 12 | 17 | 22 |
| Tax % | 27% | 27% | 27% | 20% | 27% | 29% | 34% | 20% | 29% | 28% | 24% | 17% | 26% |
| Net Profit | 10 | 9 | 8 | 11 | 14 | 9 | 9 | 10 | 10 | 16 | 9 | 15 | 16 |
| EPS (₹) | 3.23 | 2.78 | 2.56 | 3.56 | 4.37 | 2.86 | 2.83 | 3.19 | 3.18 | 5.07 | 2.89 | 4.53 | 5.06 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 87 | 70 | 67 | 101 | 128 | 115 | 144 | 176 | 225 | 191 | 175 | 215 | 232 |
| Expenses | 69 | 57 | 56 | 83 | 108 | 97 | 100 | 128 | 163 | 149 | 129 | 171 | 180 |
| Operating Profit | 19 | 12 | 10 | 18 | 20 | 19 | 44 | 48 | 62 | 43 | 46 | 44 | 52 |
| OPM % | 21% | 18% | 15% | 17% | 16% | 16% | 31% | 27% | 28% | 22% | 26% | 21% | 22% |
| Other Income | 3 | 3 | 3 | 4 | 6 | 5 | 4 | 3 | 9 | 12 | 16 | 25 | 25 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 3 |
| PBT | 20 | 14 | 12 | 20 | 24 | 22 | 47 | 50 | 69 | 52 | 59 | 67 | 74 |
| Tax % | 32% | 32% | 31% | 34% | 28% | 24% | 26% | 27% | 26% | 25% | 28% | 24% | — |
| Net Profit | 14 | 9 | 8 | 13 | 18 | 17 | 34 | 36 | 51 | 39 | 43 | 50 | 56 |
| EPS (₹) | 4.08 | 2.88 | 2.49 | 4.17 | 5.46 | 5.28 | 10.67 | 11.33 | 15.8 | 12.15 | 13.25 | 15.67 | 17.55 |
| Div. Payout % | 4% | 5% | 6% | 4% | 3% | 4% | 9% | 1% | 6% | 8% | 8% | 6% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 75 | 84 | 91 | 101 | 118 | 135 | 170 | 204 | 252 | 290 | 332 | 383 |
| Borrowings | 5 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Liabilities | 9 | 8 | 10 | 12 | 11 | 10 | 17 | 14 | 20 | 18 | 21 | 17 |
| Total Liabilities | 92 | 97 | 106 | 117 | 132 | 149 | 190 | 222 | 275 | 311 | 357 | 405 |
| Fixed Assets | 11 | 21 | 52 | 51 | 50 | 46 | 89 | 91 | 96 | 99 | 101 | 48 |
| CWIP | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Investments | 14 | 32 | 23 | 20 | 37 | 18 | 30 | 4 | 9 | 43 | 57 | 209 |
| Other Assets | 65 | 43 | 29 | 45 | 44 | 84 | 70 | 126 | 169 | 169 | 198 | 147 |
| Total Assets | 92 | 97 | 106 | 117 | 132 | 149 | 190 | 222 | 275 | 311 | 357 | 405 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | 18 | 21 | 1 | 15 | 13 | 16 | 11 | 60 | 69 | −104 | 87 |
| Investing | 13 | −26 | −24 | 5 | −16 | 26 | −54 | 26 | −8 | −30 | −7 | −77 |
| Financing | −1 | −4 | −1 | −2 | −1 | −1 | −1 | −3 | −3 | −3 | −3 | −3 |
| Net Cash Flow | 12 | −12 | −4 | 5 | −2 | 38 | −39 | 34 | 49 | 36 | −115 | 7 |
| Free Cash Flow | −10 | 7 | 19 | 1 | 14 | 13 | 15 | 11 | 57 | 65 | −111 | 106 |
| CFO/EBITDA | 38 | 186 | 226 | 37 | 111 | 100 | 61 | 54 | 123 | 197 | −194 | 242 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 30 | 28 | 32 | 27 | 26 | 22 | 21 | 21 | 26 | 33 | 18 |
| Inventory Days | 252 | 221 | 70 | 59 | 53 | 56 | 176 | 309 | 195 | 80 | 210 | 102 |
| Days Payable | 35 | 39 | 35 | 19 | 9 | 15 | 31 | 23 | 12 | 13 | 24 | 10 |
| Cash Conversion Cycle | 242 | 211 | 63 | 72 | 71 | 66 | 166 | 307 | 204 | 93 | 218 | 110 |
| Working Capital Days | 139 | 120 | 45 | 74 | 66 | 40 | 81 | 143 | 96 | 48 | 175 | 165 |
| ROCE % | 26% | 16% | 13% | 20% | 21% | 17% | 30% | 26% | 29% | 19% | 18% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Indo Borax & Chemicals insights
61 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Sep 2026Transcript PPT Recording
- Concall · Jun 2026Transcript PPT Recording
- Concall · May 2026PPT
- 10 Aug 2026
- 31 Aug 2026
- 23 Jul 2026
- General announcements 3 Nov 2026
- General announcements 22 Oct 2026
- General announcements 19 Oct 2026
Frequently Asked Questions about Indo Borax & Chemicals
What does Indo Borax & Chemicals Ltd do?
Where is Indo Borax & Chemicals Ltd (INDOBORAX) listed?
Which sector does Indo Borax & Chemicals Ltd belong to?
What is the PE ratio of Indo Borax & Chemicals Ltd?
What is the 52-week high and low of Indo Borax & Chemicals Ltd?
Does Indo Borax & Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Indo Borax & Chemicals Ltd?
Company Information
Incorporated in 1980, Indo Borax & Chemicals Ltd is in the business of manufacturing Boron and Lithium products
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INDOBORAX.md for Indo Borax & Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.